Home › Marginal Zone Lymphoma › Florida › Miami
Marginal Zone Lymphoma clinical trials in Miami, FL
7 studies for Marginal Zone Lymphoma are looking for participants at sites in and around Miami (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma
RecruitingPhase 2
- University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
- UM Sylvester Comprehensive Cancer Center at Kendall, Miami
Epcoritamab in Patients With Newly Diagnosed Marginal Zone Lymphoma (MZL)
RecruitingPhase 2
- University of Miami, Miami
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
RecruitingPhase 1/2
- Mount Sinai Medical Center Braman Comprehensive Cancer Center, Miami
Open-label of Loncastuximab Tesirine (ADCT-402) in Relapsed/Refractory Marginal Zone Lymphoma
RecruitingPhase 2
- University of Miami, Miami
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
RecruitingPhase 1
- University of Miami, Miami
Integrated Molecular and Clinical Profiling to Improve Disease Characterization and Outcome Prediction in Nodal Marginal Zone Lymphoma
RecruitingObservational study
- University of Miami, Miami
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Miami
Marginal Zone Lymphoma trials in other cities
- Durham, NC12 studies
- New York City, NY10 studies
- Milwaukee, WI9 studies
- Baldwin Park, CA9 studies
- Columbus, OH8 studies
- Boston, MA8 studies
- Seattle, WA8 studies
- Edison, NJ8 studies
- Houston, TX8 studies
- Rochester, MN7 studies
- Denver, CO7 studies
- Nashville, TN7 studies
Other studies in Miami
- Breast Cancer42 studies
- Cancer (all types)36 studies
- Non-Small Cell Lung Cancer35 studies
- Prostate Cancer30 studies
- Obesity28 studies
- Ovarian Cancer24 studies
- Acute Myeloid Leukemia24 studies
- Overweight23 studies
- Metastatic Cancer22 studies
- Multiple Myeloma22 studies
- Lung Cancer22 studies
- Alzheimer's Disease21 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.